"Dermatology"

During the past decade, Beacon Dermatology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beacon Dermatology" #1 sponsor was "Amgen" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beacon Dermatology" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Beacon Dermatology" are "Plaque Psoriasis" (3 trials), "Atopic Dermatitis" (2 trials), "Dermatitis, Atopic" (1 trials), "Psoriasis" (1 trials) and "Scalp Psoriasis" (1 trials). Many other conditions were trialed in "Beacon Dermatology" in a lesser frequency.

Most popular intervention types in "Beacon Dermatology" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ABP 501" (1 trials), "ABP 654" (1 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beacon Dermatology" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Beacon Dermatology". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Beacon Dermatology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Beacon Dermatology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".